Heights Capital Management’s Bellevue Life Sciences Acquisition Corp. Rights BLACR Stock Holding History

Heights Capital Management’s Portfolio BLACR Stock Details BLACR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$20.3K	Hold
2024 Q3	$17.1K	Buy